Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
KRX:207940
Price:
999 999.9999
KRW
Market Closed
Market Cap:
45.1T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Samsung Biologics Co Ltd
999999.9999
0.0000 (0%)
| 52 Week Range |
934 000
999 999.9999
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
|
Revenue
|
5.5T
KRW
|
|
Cost of Revenue
|
-2.4T
KRW
|
|
Gross Profit
|
3.1T
KRW
|
|
Operating Expenses
|
-1.1T
KRW
|
|
Operating Income
|
2T
KRW
|
|
Other Expenses
|
-420.9B
KRW
|
|
Net Income
|
1.6T
KRW
|
Income Statement
Samsung Biologics Co Ltd
Samsung Biologics Co Ltd
Currency: KRW
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||
| Interest Expense |
19 254
|
18 925
|
15 144
|
9 969
|
5 684
|
4 643
|
6 240
|
9 667
|
15 839
|
20 678
|
24 681
|
27 479
|
25 615
|
23 135
|
20 181
|
17 645
|
16 086
|
15 583
|
14 359
|
13 601
|
14 707
|
13 503
|
25 394
|
44 220
|
64 064
|
82 858
|
86 865
|
86 710
|
81 596
|
75 972
|
65 373
|
45 458
|
50 057
|
43 886
|
0
|
0
|
|
| Revenue |
294 622
N/A
|
313 519
+6%
|
329 199
+5%
|
403 868
+23%
|
464 629
+15%
|
488 016
+5%
|
550 229
+13%
|
523 843
-5%
|
535 806
+2%
|
530 136
-1%
|
482 788
-9%
|
566 539
+17%
|
701 592
+24%
|
783 424
+12%
|
1 013 033
+29%
|
1 102 797
+9%
|
1 164 777
+6%
|
1 218 377
+5%
|
1 322 849
+9%
|
1 499 000
+13%
|
1 568 007
+5%
|
1 818 513
+16%
|
2 057 774
+13%
|
2 480 082
+21%
|
3 001 295
+21%
|
3 210 913
+7%
|
3 425 675
+7%
|
3 586 607
+5%
|
3 694 589
+3%
|
3 920 570
+6%
|
4 211 290
+7%
|
4 364 392
+4%
|
4 547 322
+4%
|
4 898 692
+8%
|
5 031 693
+3%
|
5 504 838
+9%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(268 088)
|
(267 036)
|
(286 392)
|
(325 904)
|
(332 829)
|
(348 693)
|
(374 291)
|
(351 333)
|
(390 646)
|
(410 600)
|
(394 739)
|
(463 402)
|
(509 584)
|
(503 956)
|
(639 035)
|
(690 902)
|
(748 701)
|
(782 019)
|
(781 146)
|
(829 252)
|
(841 556)
|
(969 680)
|
(1 132 085)
|
(1 282 962)
|
(1 532 847)
|
(1 629 655)
|
(1 705 516)
|
(1 850 808)
|
(1 891 824)
|
(2 040 192)
|
(2 100 223)
|
(2 211 033)
|
(2 256 478)
|
(2 295 164)
|
(2 367 014)
|
(2 405 427)
|
|
| Gross Profit |
26 534
N/A
|
46 483
+75%
|
42 807
-8%
|
77 964
+82%
|
131 800
+69%
|
139 324
+6%
|
175 938
+26%
|
172 510
-2%
|
145 160
-16%
|
119 536
-18%
|
88 048
-26%
|
103 137
+17%
|
192 007
+86%
|
279 467
+46%
|
373 998
+34%
|
411 895
+10%
|
416 076
+1%
|
436 358
+5%
|
541 703
+24%
|
669 748
+24%
|
726 451
+8%
|
848 833
+17%
|
925 689
+9%
|
1 197 120
+29%
|
1 468 448
+23%
|
1 581 259
+8%
|
1 720 159
+9%
|
1 735 799
+1%
|
1 802 765
+4%
|
1 880 379
+4%
|
2 111 067
+12%
|
2 153 358
+2%
|
2 290 845
+6%
|
2 603 528
+14%
|
2 664 679
+2%
|
3 099 412
+16%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(56 956)
|
(59 837)
|
(61 453)
|
(63 280)
|
(65 821)
|
(66 756)
|
(71 169)
|
(77 752)
|
(89 481)
|
291 966
|
284 316
|
(106 853)
|
(100 265)
|
(101 757)
|
(99 754)
|
(104 726)
|
(123 290)
|
(131 850)
|
(151 537)
|
(168 705)
|
(189 142)
|
(209 403)
|
(283 345)
|
(397 447)
|
(484 821)
|
(582 307)
|
(637 441)
|
(659 291)
|
(689 085)
|
(737 141)
|
(786 757)
|
(809 002)
|
(970 792)
|
(1 018 086)
|
(1 038 148)
|
(1 082 611)
|
|
| Selling, General & Administrative |
(50 880)
|
(53 611)
|
(54 737)
|
(55 861)
|
(56 326)
|
(55 320)
|
(57 605)
|
(62 198)
|
(74 866)
|
(84 231)
|
(93 541)
|
(97 198)
|
(91 013)
|
(92 354)
|
(90 508)
|
(94 511)
|
(109 180)
|
(117 875)
|
(137 656)
|
(156 201)
|
(180 348)
|
(200 262)
|
(271 347)
|
(380 390)
|
(417 989)
|
(540 047)
|
(570 693)
|
(570 565)
|
(575 526)
|
(613 128)
|
(655 536)
|
(661 435)
|
(779 949)
|
(815 249)
|
(818 759)
|
(861 221)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1 091)
|
(5 106)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(45 884)
|
(16 726)
|
(38 071)
|
(59 186)
|
(81 588)
|
(89 436)
|
(94 672)
|
(103 174)
|
(144 649)
|
(155 347)
|
(169 092)
|
(173 756)
|
|
| Depreciation & Amortization |
(6 076)
|
(6 226)
|
(6 715)
|
(7 419)
|
(9 495)
|
(11 436)
|
(13 564)
|
(15 543)
|
(14 615)
|
(13 016)
|
(11 368)
|
(9 654)
|
(9 252)
|
(9 403)
|
(9 246)
|
(9 124)
|
(9 003)
|
(8 869)
|
(8 775)
|
(8 489)
|
(8 794)
|
(9 140)
|
(11 998)
|
(17 056)
|
(20 948)
|
(25 533)
|
(28 677)
|
(29 539)
|
(31 971)
|
(34 582)
|
(36 555)
|
(44 399)
|
(46 194)
|
(47 489)
|
(50 297)
|
(47 634)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
0
|
389 214
|
389 224
|
0
|
0
|
0
|
0
|
0
|
0
|
(5 106)
|
(5 106)
|
(4 014)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(30 423)
N/A
|
(13 354)
+56%
|
(18 646)
-40%
|
14 684
N/A
|
65 979
+349%
|
72 568
+10%
|
104 769
+44%
|
94 758
-10%
|
55 679
-41%
|
411 502
+639%
|
372 364
-10%
|
(3 716)
N/A
|
91 742
N/A
|
177 711
+94%
|
274 244
+54%
|
307 169
+12%
|
292 787
-5%
|
304 509
+4%
|
390 166
+28%
|
501 043
+28%
|
537 309
+7%
|
639 430
+19%
|
642 344
+0%
|
799 674
+24%
|
983 627
+23%
|
998 952
+2%
|
1 082 718
+8%
|
1 076 509
-1%
|
1 113 680
+3%
|
1 143 238
+3%
|
1 324 309
+16%
|
1 344 356
+2%
|
1 320 052
-2%
|
1 585 442
+20%
|
1 626 531
+3%
|
2 016 800
+24%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(201 657)
|
(228 243)
|
(183 458)
|
(197 435)
|
(182 728)
|
(200 064)
|
(221 184)
|
(198 880)
|
(134 354)
|
(82 975)
|
(45 810)
|
10 392
|
61 798
|
61 049
|
51 927
|
50 028
|
(25 873)
|
(6 644)
|
15 775
|
30 805
|
32 302
|
49 069
|
21 642
|
(136 593)
|
(33 549)
|
(51 475)
|
(34 744)
|
83 466
|
1 451
|
15 868
|
48 614
|
7 216
|
114 314
|
109 188
|
10 000
|
92 896
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
0
|
389 214
|
0
|
0
|
389 225
|
(359)
|
(1 712)
|
(1 712)
|
(1 712)
|
(1 352)
|
0
|
0
|
0
|
0
|
2
|
64 421
|
65 079
|
65 106
|
65 104
|
772
|
5 185
|
5 159
|
5 159
|
5 072
|
1
|
(61 769)
|
(61 769)
|
(61 769)
|
(61 769)
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
(4)
|
(4)
|
(5)
|
(45)
|
0
|
(65)
|
0
|
(612)
|
(1 008)
|
(1 098)
|
(1 099)
|
(806)
|
(475)
|
(392)
|
(1 641)
|
(1 841)
|
(1 778)
|
(1 750)
|
(3 483)
|
(7 466)
|
(7 465)
|
(8 225)
|
(6 906)
|
(2 588)
|
(2 704)
|
(1 957)
|
(1 064)
|
(3 866)
|
(3 765)
|
(4 168)
|
(3 289)
|
(2 199)
|
(2 618)
|
(2 097)
|
(2 618)
|
|
| Total Other Income |
1 180
|
1 106
|
979
|
988
|
798
|
902
|
931
|
875
|
(6 950)
|
(6 831)
|
(6 329)
|
(5 731)
|
3 060
|
3 281
|
3 167
|
2 871
|
2 272
|
1 908
|
1 069
|
412
|
(863)
|
(1 000)
|
(699)
|
(589)
|
(3 573)
|
(2 728)
|
(2 792)
|
(2 230)
|
3 563
|
2 917
|
3 235
|
3 465
|
(347)
|
(881)
|
641
|
4 001
|
|
| Pre-Tax Income |
(230 901)
N/A
|
(240 495)
-4%
|
(201 129)
+16%
|
(181 768)
+10%
|
(115 995)
+36%
|
(126 594)
-9%
|
(115 559)
+9%
|
(103 247)
+11%
|
302 976
N/A
|
320 688
+6%
|
319 126
0%
|
389 070
+22%
|
155 435
-60%
|
239 855
+54%
|
327 235
+36%
|
356 716
+9%
|
265 992
-25%
|
297 994
+12%
|
405 261
+36%
|
528 777
+30%
|
561 283
+6%
|
680 037
+21%
|
719 484
+6%
|
720 665
+0%
|
1 009 025
+40%
|
1 007 150
0%
|
1 043 997
+4%
|
1 161 866
+11%
|
1 119 987
-4%
|
1 163 416
+4%
|
1 377 062
+18%
|
1 351 748
-2%
|
1 370 052
+1%
|
1 629 361
+19%
|
1 573 306
-3%
|
2 049 311
+30%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||
| Tax Provision |
54 078
|
56 301
|
44 870
|
37 915
|
19 023
|
16 036
|
7 569
|
(26)
|
(78 867)
|
(84 597)
|
(76 916)
|
(75 734)
|
47 469
|
38 153
|
16 202
|
(1 341)
|
(25 017)
|
(32 697)
|
(70 460)
|
(118 284)
|
(167 693)
|
(200 481)
|
(209 409)
|
(213 200)
|
(210 968)
|
(214 281)
|
(218 283)
|
(224 949)
|
(262 296)
|
(268 118)
|
(348 658)
|
(299 243)
|
(286 736)
|
(349 853)
|
(287 404)
|
(453 418)
|
|
| Income from Continuing Operations |
(176 823)
|
(184 194)
|
(156 259)
|
(143 853)
|
(96 972)
|
(110 558)
|
(107 990)
|
(103 273)
|
224 109
|
236 091
|
242 210
|
313 336
|
202 904
|
278 007
|
343 437
|
355 375
|
240 975
|
265 297
|
334 801
|
410 493
|
393 589
|
479 557
|
510 074
|
507 465
|
798 056
|
792 869
|
825 714
|
936 917
|
857 691
|
895 298
|
1 028 404
|
1 052 506
|
1 083 316
|
1 279 508
|
1 285 902
|
1 595 893
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(176 823)
N/A
|
(184 194)
-4%
|
(156 259)
+15%
|
(143 853)
+8%
|
(96 972)
+33%
|
(110 558)
-14%
|
(107 990)
+2%
|
(103 273)
+4%
|
224 109
N/A
|
236 091
+5%
|
242 210
+3%
|
313 336
+29%
|
202 904
-35%
|
278 007
+37%
|
343 437
+24%
|
355 375
+3%
|
240 975
-32%
|
265 297
+10%
|
334 801
+26%
|
410 493
+23%
|
393 589
-4%
|
479 557
+22%
|
510 074
+6%
|
507 465
-1%
|
798 056
+57%
|
792 869
-1%
|
825 714
+4%
|
936 917
+13%
|
857 691
-8%
|
895 298
+4%
|
1 028 404
+15%
|
1 052 506
+2%
|
1 083 316
+3%
|
1 279 508
+18%
|
1 285 902
+0%
|
1 595 893
+24%
|
|
| EPS (Diluted) |
-3 078.58
N/A
|
-2 751.28
+11%
|
-2 334.01
+15%
|
-2 148.7
+8%
|
-1 448.46
+33%
|
-1 651.4
-14%
|
-1 613.03
+2%
|
-1 542.58
+4%
|
3 347.49
N/A
|
3 526.46
+5%
|
3 617.85
+3%
|
4 680.26
+29%
|
3 030.75
-35%
|
4 152.56
+37%
|
5 129.88
+24%
|
5 308.2
+3%
|
3 599.41
-32%
|
3 962.71
+10%
|
5 000.89
+26%
|
6 131.49
+23%
|
5 879
-4%
|
7 163.08
+22%
|
7 219.15
+1%
|
7 129.92
-1%
|
11 431.88
+60%
|
11 139.86
-3%
|
11 601.34
+4%
|
13 163.75
+13%
|
12 050.62
-8%
|
12 578.99
+4%
|
14 449.15
+15%
|
14 787.78
+2%
|
15 220.66
+3%
|
17 977.17
+18%
|
18 067.01
+0%
|
22 422.41
+24%
|
|
Switch to:
Switch to:
See Also
Discover More
